The market's held on to the Microsoft induced strength from the after-hours session last night. It looks like the Nasdaq will open just above its August lows while the S&P will open just below its August lows. It'll be interesting to see if those August levels do indeed flip from support to resistance.
On Today's Calendar:
- nothing
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent 'Chart Reading' posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
In reaction to weak earnings/guidance: SYNA -20.6%, TPX -11.7%, ITI -10.4%, TGI -8.5%, ZION -7.5%, VSEA -6.9% (also tgt cut to $51 at Stifel), IDTI -6.8% (also downgraded to Hold at Citigroup), STKL -5.9%, RDY -5.5%, IBKR -4.4%, LABL -3.3%, KLAC -1.4%, DV -1.3%, UB -1.2%... South African mining cos trading lower after country's national power utility, Eskom, said it could not guarantee today's power supply: GFI -11.1%, DROOY -10.7%, HMY -9.7%, AU -8.3%... Other news: MBRK -6.3% (announces an 8.75 mln share common stock private placement offering priced at $2.40/share), RIGL -4.4% (announces offering of 4 mln shares of common stock), DBTK -4.0% (files S-3 for the sale of 3.18 mln shares by selling stockholders)... Analyst downgrades: IDTI -6.7% (downgraded to Hold at Citigroup), SNV -2.1% (downgraded to Mkt Perform at Keefe Bruyette).
Gapping Up
In reaction to strong earnings/guidance: SCSC +26.4% (also upgraded to Peer Perform at Bear Sterns), PKI +18.9%, EZPW +14.5%, VPRT +13.6%, BRCM +13.3%, CVTI +12.6%, ETFC +9.2%, LSCC +9.0%, INSW +8.3%, EXTR +7.3%, CPWR +6.4% (also upgraded to Buy at Piper), CNXT +6.3%, RLRN +6.0%, WFR +5.4% (also tgt raised at Piper), JNPR +5.2%, MCHP +5.1% (also upgraded to Outperform at Credit Suisse), MSFT +4.5%, EMN +4.4% (also expects strategic initiatives to double EPS to $10 by 2012), AMGN +4.1% (also announces Denosumab Osteoporosis study met primary and all secondary bone mineral density endpoints), OPWV + 4.0%, PRST + 3.5%, CRDC + 3.4%, FRNT +3.4%, PMCS +2.5%, APEI +2.1%, CAT +1.9%, CSH +1.9%, ESIO +1.9%, BKUNA +1.8%, PII +1.8%, JJSF +1.6%, LEG +1.5%, KNSY +1.4%, JAVA +1.4%, HON +1.4%, LRCX +1.3%, APOG +1.3%, ABFS +1.1%... M&A news: RSTO +7.5% (enters into amendment to merger agreement with Catterton Partners; $4.50/share in cash)... Select tech stocks showing strength with several companies reporting earnings in the sector: BIDU +4.8%, CSCO +3.5%, MRVL +3.2%, RIMM +2.4%, GOOG +2.4%, DELL +2.2%, INTC +1.9%... Other news: CNIC +13.0% (announces agreement with Yellow Pages Group to provide local content to the Mamma.Com search engine), ABK +13.0% (Wilbur Ross in takeover talks with ABK, according to U.K.'s Evening Standard - Reuters), RFMD +8.6% (still checking), GFG +7.5% (Carl Icahn discloses 9.8% stake in SC 13D filing), ESLR +5.2% (ESLR and MMWEC announce joint effort to promote solar use in municipal utility communities), TMA +3.4% (Richard Rainwater discloses 13% stake in SC 13D), BSC +3.4% (Cramer discusses possibility of M&A on MadMoney), NVDA +3.2% (working on first GPGPUs for Apple Macs - AppleInsider), NUVO +3.1% (announces results from Phase 3 NAPA program in Acute Peripheral Arterial Occlusion), FCX +3.1% (still checking), MBI +2.8% (up in sympathy with ABK), BHP +2.7% (Coal shortage at BHP may lift steel price), CHINA +2.5% (provides update on insider buying), TOL +2.3% (Cramer makes positive comments on MadMoney), ARNA +2.2% (announces that MRK initiated a Phase 1 clinical trial of a second generation oral niacin receptor), CHL +2.1% (CEO sees 6 mln net new customers per month in 2008 - DJ), BAC +1.5% (prices $12 bln in depositary shares and convertible preferred stock)... Analyst upgrades: SPWR +6.6% (upgraded to Buy at Piper), CTRP +5.3% (upgraded to Buy at Piper), MT +3.3% (upgraded to Buy at Citigroup and Deutsche Bank), PNK +3.3% (upgraded to Overweight at Thomas Weisel), HAL +2.7% (upgraded to Overweight at Morgan Stanley), NYX +2.3% (upgraded to Buy at Piper), WB +1.8% (upgraded to Neutral at Merrill), OVTI +1.7% (upgraded to Outperform at Baird), VIGN +1.0% (upgraded to Buy at ThinkEquity).
Disclaimer & How I use this list



















